Multiple Sclerosis Society of Canada

Targeted Competitions

In addition to general funding opportunities that encompass the breadth of topics in MS research, the MS Society administers a number of targeted research funding competitions to address priority research areas and accelerate the translation of research into outcomes that will make a meaningful impact for people living with MS. Many of these funding opportunities are available through collaborations with other organizations that allow us to leverage expertise and resources across all sectors of research. Be sure to check back often as we will be updating this section with new targeted funding opportunities as they arise.

Contract Research Organization (CRO) Grant

The MS Society of Canada is pleased to announce the launch of a new research funding competition – the Contract Research Organization (CRO) Grant. The CRO Grant will enable principal investigators to apply for funding to pay for specific research services offered by CROs and specialized drug discovery and development organizations, with the aim of advancing research and development of treatments for progressive MS.

***Competition Now OPEN***


Centre for Drug Research and Development

The partnership between the Centre for Drug Research and Development (CDRD) and the MS Society represents an opportunity for researchers at the cutting edge of MS research to move their technologies through preclinical development and facilitate translation to patients.


Hermès Canada | MS Society Wellness Research Innovation Grant

The MS Scientific Research Foundation is pleased to launch the Hermès Canada | MS Society Wellness Research Innovation Grant, a funding opportunity that aims to translate research findings into innovative wellness solutions that will improve health and quality of life for people affected by MS.


Progressive MS Alliance

The Progressive MS Alliance (Alliance) is connecting resources and experts around the world to find answers and develop solutions to end progressive MS. The Alliance's members have made a joint commitment to speed up the development of treatment for progressive MS by removing scientific and technology barriers.